Compare BIVI & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIVI | ABTS |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2M | 14.1M |
| IPO Year | N/A | N/A |
| Metric | BIVI | ABTS |
|---|---|---|
| Price | $1.55 | $5.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 71.9K | 24.5K |
| Earning Date | 11-10-2025 | 08-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,037,156.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.69 |
| 52 Week Low | $1.25 | $1.35 |
| 52 Week High | $30.90 | $14.10 |
| Indicator | BIVI | ABTS |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 46.19 |
| Support Level | $1.45 | $5.92 |
| Resistance Level | $1.70 | $6.84 |
| Average True Range (ATR) | 0.10 | 0.71 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 63.33 | 45.41 |
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.